UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ARGX — Argenx SE
CIK 861177
NEW YORK, NY
Position in ARGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$56,883,432
+$36,797,176 QoQ
Shares Held
61,312
+122.9% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#58
of 505 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ARGX ranks #16 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in ARGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,883,432 | 61,312 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $20,086,256 | 27,506 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $18,084,629 | 21,505 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $13,460,240 | 24,419 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $337,363 | 570 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $12,561,375 | 20,425 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,139,629 | 40,842 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $395,205 | 919 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $17,185,877 | 43,650 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,631,336 | 38,460 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,208,081 | 30,934 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $13,437,500 | 34,479 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $12,846,185 | 34,479 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $15,207,372 | 40,143 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,141,768 | 40,056 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,459,925 | 46,083 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,223,959 | 51,454 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $17,265,765 | 49,304 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,877,046 | 52,573 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,362,551 | 54,348 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $14,668,646 | 53,265 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $20,614,532 | 70,096 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $12,688,902 | 48,335 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $12,159,715 | 53,988 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $10,864,562 | 82,476 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||